The 44 rating InvestorsObserver gives to Adamas Pharmaceuticals Inc (ADMS) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 75 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, ADMS’s 44 overall rating means the stock scores better than 44 percent of all stocks.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 44 means the stock is more attractive than 44 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Adamas Pharmaceuticals Inc Stock Today?
Adamas Pharmaceuticals Inc (ADMS) stock is up 2.73% while the S&P 500 is down -1.12% as of 2:15 PM on Wednesday, Sep 23. ADMS is up $0.13 from the previous closing price of $4.76 on volume of 386,308 shares. Over the past year the S&P 500 is higher by 10.51% while ADMS is down -33.01%. ADMS lost -$2.79 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Adamas Pharmaceuticals Inc (ADMS) Stock.
